Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Jones

Showing results (141-150 of 945) with videos related to

Pageof 95
Sort By:
Antimicrobial Agents and Chemotherapy|February 24, 2001
Potencies of newer fluoroquinolones against Viridans group Streptococciisolated in 637 cases of bloodstream infection in the SENTRY Antimicrobial Surveillance Program (1997 to 1999): beyond Canada!R N Jones, M A Pfaller
Diagnostic Microbiology and Infectious Disease|May 1, 1995
Antimicrobial activity of cefotaxime tested against infrequently isolated pathogenic species (unusual pathogens)M G Cormican, R N Jones
American Journal of Clinical Pathology|October 1, 1983
Special topics in antimicrobial susceptibility testing: test accuracy against methicillin-resistant Staphylococcus aureus, pneumococci, and the sensitivity of beta-lactamase methodsR N Jones, D C Edson
The Journal of Antimicrobial Chemotherapy|January 1, 1982
A three category system for interpretation of disk tests for Pseudomonas-active penicillins and beta-lactamase hydrolysis/inhibition studiesA L Barry, R N Jones
Revista Da Associacao Medica Brasileira (1992)|March 1, 1995
[Cephalosporins: 4 generations of structural evolution]H S Sader, R N Jones
Diagnostic Microbiology and Infectious Disease|July 1, 1996
In vitro activity of quinupristin/dalfopristin (RP 59500) against a large collection of infrequently isolated or tested speciesM S Barrett, R N Jones
Diagnostic Microbiology and Infectious Disease|August 1, 1997
A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wideM A Pfaller, R N Jones
American Journal of Clinical Pathology|October 1, 1982
The ability of participant laboratories to detect penicillin-resistant Pneumococci. A report from the microbiology portion of the College of American Pathologists (CAP) surveysR N Jones, D C Edson
Antimicrobial Agents and Chemotherapy|December 1, 1982
Antimicrobial activity of amikacin combinations against Enterobacteriaceae moderately susceptible to third-generation cephalosporinsR N Jones, R R Packer
Brain Research|January 27, 1980
Neurofilament proteins of mammals compared by peptide mappingP F Davison, R N Jones
Pageof 95

Showing results (141-150 of 945) with videos related to

Sort By:
Pageof 95
Antimicrobial Agents and Chemotherapy|February 24, 2001
Potencies of newer fluoroquinolones against Viridans group Streptococciisolated in 637 cases of bloodstream infection in the SENTRY Antimicrobial Surveillance Program (1997 to 1999): beyond Canada!R N Jones, M A Pfaller
Diagnostic Microbiology and Infectious Disease|May 1, 1995
Antimicrobial activity of cefotaxime tested against infrequently isolated pathogenic species (unusual pathogens)M G Cormican, R N Jones
American Journal of Clinical Pathology|October 1, 1983
Special topics in antimicrobial susceptibility testing: test accuracy against methicillin-resistant Staphylococcus aureus, pneumococci, and the sensitivity of beta-lactamase methodsR N Jones, D C Edson
The Journal of Antimicrobial Chemotherapy|January 1, 1982
A three category system for interpretation of disk tests for Pseudomonas-active penicillins and beta-lactamase hydrolysis/inhibition studiesA L Barry, R N Jones
Revista Da Associacao Medica Brasileira (1992)|March 1, 1995
[Cephalosporins: 4 generations of structural evolution]H S Sader, R N Jones
Diagnostic Microbiology and Infectious Disease|July 1, 1996
In vitro activity of quinupristin/dalfopristin (RP 59500) against a large collection of infrequently isolated or tested speciesM S Barrett, R N Jones
Diagnostic Microbiology and Infectious Disease|August 1, 1997
A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wideM A Pfaller, R N Jones
American Journal of Clinical Pathology|October 1, 1982
The ability of participant laboratories to detect penicillin-resistant Pneumococci. A report from the microbiology portion of the College of American Pathologists (CAP) surveysR N Jones, D C Edson
Antimicrobial Agents and Chemotherapy|December 1, 1982
Antimicrobial activity of amikacin combinations against Enterobacteriaceae moderately susceptible to third-generation cephalosporinsR N Jones, R R Packer
Brain Research|January 27, 1980
Neurofilament proteins of mammals compared by peptide mappingP F Davison, R N Jones
Pageof 95